ZE63-0302
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZE63-0302, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers [Phase 1]